Neuropeptide Systems in Substance use Disorders: Therapeutic evidence and molecular mechanisms

Nazila Nejhaddadgar, Nafiseh Sadat Imani, Khatereh Isazadehfar, Zhaleh Jamali

Open source

DOI
10.1016/j.npep.2026.102666
Published
2026-12
Container
Neuropeptides
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.npep.2026.102666,
  title = {Neuropeptide Systems in Substance use Disorders: Therapeutic evidence and molecular mechanisms},
  author = {Nazila Nejhaddadgar and Nafiseh Sadat Imani and Khatereh Isazadehfar and Zhaleh Jamali},
  year = {2026},
  journal = {Neuropeptides},
  doi = {10.1016/j.npep.2026.102666},
  url = {https://doi.org/10.1016/j.npep.2026.102666}
}

RIS

TY  - JOUR
TI  - Neuropeptide Systems in Substance use Disorders: Therapeutic evidence and molecular mechanisms
AU  - Nazila Nejhaddadgar
AU  - Nafiseh Sadat Imani
AU  - Khatereh Isazadehfar
AU  - Zhaleh Jamali
PY  - 2026
JO  - Neuropeptides
DO  - 10.1016/j.npep.2026.102666
UR  - https://doi.org/10.1016/j.npep.2026.102666
ER  - 

APA

Nejhaddadgar, N., Imani, N. S., Isazadehfar, K., & Jamali, Z. (2026). Neuropeptide Systems in Substance use Disorders: Therapeutic evidence and molecular mechanisms. Neuropeptides. https://doi.org/10.1016/j.npep.2026.102666

Source records